TLTFF
Price:
$0.112
Market Cap:
$39.84M
Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds (PDCs) and their associated drug formulations to treat cancer, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. In addition, the company develops TLD-1433, which is in Phase II for the treatment of Bacillus Calmette Guérin - Unresponsive Carcinoma In-Situ non-muscle invasive bladder cancer. Further, its produc...[Read more]
Industry
Medical - Devices
IPO Date
2010-04-05
Stock Exchange
OTC
Ticker
TLTFF
According to Theralase Technologies Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.96. This represents a change of -27.62% compared to the average of 1.33 of the last 4 quarters.
The mean historical Current Ratio of Theralase Technologies Inc. over the last ten years is 5.42. The current 0.96 Current Ratio has changed 1.67% with respect to the historical average. Over the past ten years (40 quarters), TLTFF's Current Ratio was at its highest in in the September 2019 quarter at 19.66. The Current Ratio was at its lowest in in the March 2025 quarter at 0.82.
Average
5.42
Median
4.69
Minimum
1.07
Maximum
10.85
Discovering the peaks and valleys of Theralase Technologies Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 772.59%
Maximum Annual Current Ratio = 10.85
Minimum Annual Increase = -80.52%
Minimum Annual Current Ratio = 1.07
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 1.61 | 15.46% |
| 2023 | 1.39 | -62.09% |
| 2022 | 3.67 | -35.77% |
| 2021 | 5.71 | -47.36% |
| 2020 | 10.85 | 16.28% |
| 2019 | 9.33 | 772.59% |
| 2018 | 1.07 | -46.27% |
| 2017 | 1.99 | -80.52% |
| 2016 | 10.22 | 21.76% |
| 2015 | 8.39 | 25.46% |
The current Current Ratio of Theralase Technologies Inc. (TLTFF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.22
5-year avg
4.65
10-year avg
5.42
Theralase Technologies Inc.’s Current Ratio is less than Vivos Inc. (28.77), less than Novacyt S.A. (6.33), greater than Drug Free Solution, Inc. (0.04), less than Nova Eye Medical Limited (2.39), less than Cynata Therapeutics Limited (4.40), greater than MedMira Inc. (0.07), greater than Sernova Corp. (0.12), less than Bioqual, Inc. (3.72), less than PetVivo Holdings, Inc. (2.00), less than Medical Developments International Limited (4.54),
| Company | Current Ratio | Market cap |
|---|---|---|
| 28.77 | $33.04M | |
| 6.33 | $36.02M | |
| 0.04 | $488.90K | |
| 2.39 | $28.48M | |
| 4.40 | $35.62M | |
| 0.07 | $15.51M | |
| 0.12 | $32.87M | |
| 3.72 | $34.44M | |
| 2.00 | $26.03M | |
| 4.54 | $36.12M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theralase Technologies Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Theralase Technologies Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Theralase Technologies Inc.'s Current Ratio?
How is the Current Ratio calculated for Theralase Technologies Inc. (TLTFF)?
What is the highest Current Ratio for Theralase Technologies Inc. (TLTFF)?
What is the 3-year average Current Ratio for Theralase Technologies Inc. (TLTFF)?
What is the 5-year average Current Ratio for Theralase Technologies Inc. (TLTFF)?
How does the current Current Ratio for Theralase Technologies Inc. (TLTFF) compare to its historical average?